Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 13.05
+0.15 (1.16%)
May 14, 2025, 1:27 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 5.51 billion as of May 14, 2025. Its market cap has decreased by -20.51% in one year.
Market Cap
5.51B
Enterprise Value
5.32B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.05
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 5.51B, an increase of 7.86%. That is a compound annual growth rate of 3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 5.44B | -1.02% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 169.19B |
| Caliway Biopharmaceuticals | 122.30B |
| Bora Pharmaceuticals Co., LTD. | 75.66B |
| Lotus Pharmaceutical | 59.51B |
| Polaris Group | 31.97B |
| Oneness Biotech | 29.80B |
| Pegavision | 27.77B |
| Lumosa Therapeutics | 27.11B |